BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 21403839)

  • 1. Intervening in β-catenin signaling by sulindac inhibits S100A4-dependent colon cancer metastasis.
    Stein U; Arlt F; Smith J; Sack U; Herrmann P; Walther W; Lemm M; Fichtner I; Shoemaker RH; Schlag PM
    Neoplasia; 2011 Feb; 13(2):131-44. PubMed ID: 21403839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor signaling in colon cancer.
    Stein U; Arlt F; Walther W; Smith J; Waldman T; Harris ED; Mertins SD; Heizmann CW; Allard D; Birchmeier W; Schlag PM; Shoemaker RH
    Gastroenterology; 2006 Nov; 131(5):1486-500. PubMed ID: 17101323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.
    Sack U; Walther W; Scudiero D; Selby M; Kobelt D; Lemm M; Fichtner I; Schlag PM; Shoemaker RH; Stein U
    J Natl Cancer Inst; 2011 Jul; 103(13):1018-36. PubMed ID: 21685359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S100A4-induced cell motility and metastasis is restricted by the Wnt/β-catenin pathway inhibitor calcimycin in colon cancer cells.
    Sack U; Walther W; Scudiero D; Selby M; Aumann J; Lemos C; Fichtner I; Schlag PM; Shoemaker RH; Stein U
    Mol Biol Cell; 2011 Sep; 22(18):3344-54. PubMed ID: 21795396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt up your mind - intervention strategies for S100A4-induced metastasis in colon cancer.
    Sack U; Stein U
    Gen Physiol Biophys; 2009; 28 Spec No Focus():F55-64. PubMed ID: 20093727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Niclosamide: an established antihelminthic drug as a potential therapy against S100A4-mediated metastatic colon tumors.
    Helfman DM
    J Natl Cancer Inst; 2011 Jul; 103(13):991-2. PubMed ID: 21685360
    [No Abstract]   [Full Text] [Related]  

  • 7. S100A4 negatively regulates β-catenin by inducing the Egr-1-PTEN-Akt-GSK3β degradation pathway.
    Yang W; Nam K; Ju JH; Lee KM; Oh S; Shin I
    Cell Signal; 2014 Oct; 26(10):2096-106. PubMed ID: 24975844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt-beta-catenin pathway signals metastasis-associated tumor cell phenotypes in triple negative breast cancers.
    De P; Carlson JH; Wu H; Marcus A; Leyland-Jones B; Dey N
    Oncotarget; 2016 Jul; 7(28):43124-43149. PubMed ID: 27281609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cinobufacini Inhibits Colon Cancer Invasion and Metastasis via Suppressing Wnt/β-Catenin Signaling Pathway and EMT.
    Wang J; Cai H; Liu Q; Xia Y; Xing L; Zuo Q; Zhang Y; Chen C; Xu K; Yin P; Chen T
    Am J Chin Med; 2020; 48(3):703-718. PubMed ID: 32329642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of S100A4 in human cancer cell lines resistant to methotrexate.
    Mencía N; Selga E; Rico I; de Almagro MC; Villalobos X; Ramirez S; Adan J; Hernández JL; Noé V; Ciudad CJ
    BMC Cancer; 2010 Jun; 10():250. PubMed ID: 20515499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inhibition of Wnt/β-catenin signaling pathway in human colon cancer cells by sulindac.
    Tai WP; Hu PJ; Wu J; Lin XC
    Tumori; 2014; 100(1):97-101. PubMed ID: 24675499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel sulindac derivative that potently suppresses colon tumor cell growth by inhibiting cGMP phosphodiesterase and β-catenin transcriptional activity.
    Whitt JD; Li N; Tinsley HN; Chen X; Zhang W; Li Y; Gary BD; Keeton AB; Xi Y; Abadi AH; Grizzle WE; Piazza GA
    Cancer Prev Res (Phila); 2012 Jun; 5(6):822-33. PubMed ID: 22556201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The intestine-specific transcription factor Cdx2 inhibits beta-catenin/TCF transcriptional activity by disrupting the beta-catenin-TCF protein complex.
    Guo RJ; Funakoshi S; Lee HH; Kong J; Lynch JP
    Carcinogenesis; 2010 Feb; 31(2):159-66. PubMed ID: 19734199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein-bound polysaccharide from Phellinus linteus inhibits tumor growth, invasion, and angiogenesis and alters Wnt/β-catenin in SW480 human colon cancer cells.
    Song KS; Li G; Kim JS; Jing K; Kim TD; Kim JP; Seo SB; Yoo JK; Park HD; Hwang BD; Lim K; Yoon WH
    BMC Cancer; 2011 Jul; 11():307. PubMed ID: 21781302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells.
    Sinner D; Kordich JJ; Spence JR; Opoka R; Rankin S; Lin SC; Jonatan D; Zorn AM; Wells JM
    Mol Cell Biol; 2007 Nov; 27(22):7802-15. PubMed ID: 17875931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel genome-wide in vivo screen for metastatic suppressors in human colon cancer identifies the positive WNT-TCF pathway modulators TMED3 and SOX12.
    Duquet A; Melotti A; Mishra S; Malerba M; Seth C; Conod A; Ruiz i Altaba A
    EMBO Mol Med; 2014 Jul; 6(7):882-901. PubMed ID: 24920608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of PDE5 by sulindac sulfide selectively induces apoptosis and attenuates oncogenic Wnt/β-catenin-mediated transcription in human breast tumor cells.
    Tinsley HN; Gary BD; Keeton AB; Lu W; Li Y; Piazza GA
    Cancer Prev Res (Phila); 2011 Aug; 4(8):1275-84. PubMed ID: 21505183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fascin, a novel target of beta-catenin-TCF signaling, is expressed at the invasive front of human colon cancer.
    Vignjevic D; Schoumacher M; Gavert N; Janssen KP; Jih G; Laé M; Louvard D; Ben-Ze'ev A; Robine S
    Cancer Res; 2007 Jul; 67(14):6844-53. PubMed ID: 17638895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of atorvastatin with sulindac or naproxen profoundly inhibits colonic adenocarcinomas by suppressing the p65/β-catenin/cyclin D1 signaling pathway in rats.
    Suh N; Reddy BS; DeCastro A; Paul S; Lee HJ; Smolarek AK; So JY; Simi B; Wang CX; Janakiram NB; Steele V; Rao CV
    Cancer Prev Res (Phila); 2011 Nov; 4(11):1895-902. PubMed ID: 21764859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WNT10B functional dualism: beta-catenin/Tcf-dependent growth promotion or independent suppression with deregulated expression in cancer.
    Yoshikawa H; Matsubara K; Zhou X; Okamura S; Kubo T; Murase Y; Shikauchi Y; Esteller M; Herman JG; Wei Wang X; Harris CC
    Mol Biol Cell; 2007 Nov; 18(11):4292-303. PubMed ID: 17761539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.